Viewing Study NCT00263211



Ignite Creation Date: 2024-05-05 @ 4:34 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00263211
Status: TERMINATED
Last Update Posted: 2017-03-15
First Post: 2005-12-06

Brief Title: A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Sponsor: Washington University School of Medicine
Organization: Washington University School of Medicine

Study Overview

Official Title: The Impact Of Platelet Function Inhibition On Circulating Cancer Cells In Metastatic Breast Cancer Patients
Status: TERMINATED
Status Verified Date: 2017-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Stopped due to low percentage of patients with detectable CTCs at baseline
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine the effects of Plavix and aspirin in women with metastatic breast cancer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None